Since the publishing of the Kanavape decision in November 2020, some EU member states are still non-compliant with it, and a number of member states still view as illegal CBD-containing vape products, hemp flowers, and extraction from flowers. This report aims to analyse the developments of the European CBD regulatory landscape almost one and a half years after the crucial ruling of the Kanavape case. Specifically, the analysis focuses on the compliance by EU member states with the decision of the Court of Justice of the European Union (CJEU) in different policy areas and the direct impact on European Commission (EC) policy decisions.
“ Regulatory report: the Kanavape ruling’s impact on EU harmonisation of CBD ”
Buy report request information:
“ Regulatory report: the Kanavape ruling’s impact on EU harmonisation of CBD ”
We also invite you to enjoy our FREE TRIAL
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.